JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2024

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2024

Notification Letter and Reply Form for Registered Shareholders

Notification Letter and Reply Form for Registered Shareholders

Notification Letter and Request Form for Non-Registered Shareholders

Notification Letter and Request Form for Non-Registered Shareholders

UPDATE ANNOUNCEMENT CONNECTED TRANSACTION ESTABLISHMENT OF PARTNERSHIP FUND

UPDATE ANNOUNCEMENT CONNECTED TRANSACTION ESTABLISHMENT OF PARTNERSHIP FUND

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024

(1) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; AND (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

(1) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; AND (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

Terms of Reference of the Audit Committee of the Board of Directors

Terms of Reference of the Audit Committee of the Board of Directors

Terms of Reference of the Nomination Committee of the Board of Directors

Terms of Reference of the Nomination Committee of the Board of Directors

Terms of Reference of the Remuneration and Evaluation Committee of the Board of Directors

Terms of Reference of the Remuneration and Evaluation Committee of the Board of Directors

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top